Todays’ reports contain some interesting data, although it is not entirely clear how they should best be applied in the diagnosis and potential management of patients at risk:
- A study of patient preferences and decision making about how to be treated
- Why some Brazilian men reject digital rectal examination (fewer that you might expect)
- The natural history of high-grade prostatic intraepithelial neoplasia (HGPIN)
- The potential of ferumoxtran-10 (Combidex) in diagnosis of lymph node metastases … READ MORE …
Filed under: Diagnosis, Management | Tagged: cancer, Combidex, DRE, ferumoxtran-10, HGPIN, news, preferences, prostate, update | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 